Given that most RBP mutations causing ALS–FTD are located in IDR, it is not surprising that ALS–FTD-associated mutant FUS, HNRNPA1 and TIA1 exhibit a greater propensity to undergo LLPS at lower saturation concentration. The gene discussed is HNRNPA1; the disease is amyotrophic lateral sclerosis.